NEW YORK (GenomeWeb News) - Less than two years after unveiling its initial offering of instruments, Invitrogen CEO Greg Lucier told investors during the firm’s first-quarter conference call last month that the development of small instrument systems would continue to be a focused part of Invitrogen’s growth strategy and that a transplant diagnostics system would soon hit the market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.